Last reviewed · How we verify
HuangKui Capsule
At a glance
| Generic name | HuangKui Capsule |
|---|---|
| Sponsor | Jiangsu Famous Medical Technology Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease (EARLY_PHASE1)
- Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy (PHASE4)
- Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HuangKui Capsule CI brief — competitive landscape report
- HuangKui Capsule updates RSS · CI watch RSS
- Jiangsu Famous Medical Technology Co., Ltd. portfolio CI